Inhibition of Plasma Kallikrein by a Highly Specific Active Site Blocking Antibody-Reference-Cited by-同舟云学术

Inhibition of Plasma Kallikrein by a Highly Specific Active Site Blocking Antibody

Published:2014-08 Issue:34 Volume:289 Page:23596-23608
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Kenniston Jon A.,Faucette Ryan R.,Martik Diana,Comeau Stephen R.,Lindberg Allison P.,Kopacz Kris J.,Conley Gregory P.,Chen Jie,Viswanathan Malini,Kastrapeli Niksa,Cosic Janja,Mason Shauna,DiLeo Mike,Abendroth Jan,Kuzmic Petr,Ladner Robert C.,Edwards Thomas E.,TenHoor Christopher,Adelman Burt A.,Nixon Andrew E.,Sexton Daniel J.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference79 articles.

1. Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes;Colman;Blood,1997

2. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences;Leeb-Lundberg;Pharmacol. Rev,2005

3. Mast cells increase vascular permeability by heparin-initiated bradykinin formation in vivo;Oschatz;Immunity,2011

4. Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation;Maas;J. Clin. Invest,2008

5. Dual role of collagen in factor XII-dependent thrombus formation;van der Meijden;Blood,2009

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma kallikrein supports FXII-independent thrombin generation in mouse whole blood;Blood Advances;2024-06-12

2. Phage Display as a Medium for Target Therapy Based Drug Discovery, Review and Update;Molecular Biotechnology;2024-06-01

3. A quantitative systems pharmacology model of plasma kallikrein-kinin system dysregulation in hereditary angioedema;Journal of Pharmacokinetics and Pharmacodynamics;2024-05-11

4. Effect of lanadelumab on attack frequency and QoL in Japanese patients with hereditary angioedema: Report of five cases;The Journal of Dermatology;2024-01-25

5. Oral FXIIa inhibitor KV998086 suppresses FXIIa and single chain FXII mediated kallikrein kinin system activation;Frontiers in Pharmacology;2023-12-19